Evolus Inc. [EOLS] Revenue clocked in at $56.50 million, up 183.04% YTD: What’s Next?

Evolus Inc. [NASDAQ: EOLS] price plunged by -18.86 percent to reach at -$2.21. The company report on April 22, 2021 that Evolus Announces Pricing of Public Offering of Common Stock.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Evolus, Inc. (Nasdaq: EOLS) announced the pricing of its public offering of 9,000,000 shares of its common stock at a public offering price of $9.50 per share, before underwriting discounts and commissions. The gross proceeds from the offering to Evolus are expected to be $85.5 million, before deducting underwriting discounts and commissions and offering expenses. In addition, Evolus has granted the underwriters a 30-day option to purchase up to an additional 1,350,000 shares of common stock at the public offering price, less the underwriting discounts and commissions. The offering is expected to close on or about April 26, 2021, subject to satisfaction of customary closing conditions. All the shares in the offering are being sold by Evolus.

Evolus intends to use the net proceeds of the offering to continue to fund the U.S. growth of Jeuveau®, European pre-launch activities and general corporate purposes.

A sum of 7558401 shares traded at recent session while its average daily volume was at 1.57M shares. Evolus Inc. shares reached a high of $9.99 and dropped to a low of $9.25 until finishing in the latest session at $9.51.

The one-year EOLS stock forecast points to a potential upside of 45.12. The average equity rating for EOLS stock is currently 2.40, trading closer to a bullish pattern in the stock market.

Guru’s Opinion on Evolus Inc. [EOLS]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EOLS shares is $17.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EOLS stock is a recommendation set at 2.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

H.C. Wainwright have made an estimate for Evolus Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 08, 2021. The new note on the price target was released on February 24, 2021, representing the official price target for Evolus Inc. stock. Previously, the target price had yet another drop from $8 to $3, while Mizuho kept a Neutral rating on EOLS stock.

The Average True Range (ATR) for Evolus Inc. is set at 1.44, with the Price to Sales ratio for EOLS stock in the period of the last 12 months amounting to 7.56.

EOLS Stock Performance Analysis:

Evolus Inc. [EOLS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -15.62. With this latest performance, EOLS shares dropped by -40.89% in over the last four-week period, additionally plugging by 141.98% over the last 6 months – not to mention a rise of 122.72% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EOLS stock in for the last two-week period is set at 37.72, with the RSI for the last a single of trading hit 31.65, and the three-weeks RSI is set at 42.42 for Evolus Inc. [EOLS]. The present Moving Average for the last 50 days of trading for this stock 11.83, while it was recorded at 10.67 for the last single week of trading, and 5.99 for the last 200 days.

Insight into Evolus Inc. Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Evolus Inc. [EOLS] shares currently have an operating margin of -121.50 and a Gross Margin at +55.21. Evolus Inc.’s Net Margin is presently recorded at -288.31.

Return on Total Capital for EOLS is now -56.93, given the latest momentum, and Return on Invested Capital for the company is -224.08. Return on Equity for this stock declined to -5,016.56, with Return on Assets sitting at -72.53. Additionally, EOLS Total Debt to Total Capital is recorded at 211.63, with Total Debt to Total Assets ending up at 66.16.

Reflecting on the efficiency of the workforce at the company, Evolus Inc. [EOLS] managed to generate an average of -$1,369,857 per employee. Receivables Turnover for the company is 5.56 with a Total Asset Turnover recorded at a value of 0.25.Evolus Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.70 and a Current Ratio set at 0.70.


With the latest financial reports released by the company, Evolus Inc. posted -0.75/share EPS, while the average EPS was predicted by analysts to be reported at -0.59/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -27.10%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EOLS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Evolus Inc. go to 16.50%.

Evolus Inc. [EOLS] Insider Position Details

There are presently around $74 million, or 18.70% of EOLS stock, in the hands of institutional investors. The top three institutional holders of EOLS stocks are: BLACKROCK INC. with ownership of 1,482,635, which is approximately -16.337% of the company’s market cap and around 18.60% of the total institutional ownership; SCHRODER INVESTMENT MANAGEMENT GROUP, holding 1,376,459 shares of the stock with an approximate value of $13.09 million in EOLS stocks shares; and VANGUARD GROUP INC, currently with $9.0 million in EOLS stock with ownership of nearly -0.921% of the company’s market capitalization.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Positions in Evolus Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 36 institutional holders increased their position in Evolus Inc. [NASDAQ:EOLS] by around 1,533,803 shares. Additionally, 42 investors decreased positions by around 1,087,676 shares, while 23 investors held positions by with 5,140,521 shares. The mentioned changes placed institutional holdings at 7,762,000 shares, according to the latest SEC report filing. EOLS stock had 17 new institutional investments in for a total of 720,820 shares, while 18 institutional investors sold positions of 440,663 shares during the same period.

Share on facebook
Share on twitter
Share on linkedin
Share on skype
Share on reddit

Leave a Comment

Your email address will not be published. Required fields are marked *

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam